We narrowed to 315 results for: ids

1. pAAV-S5E2-Gq-P2A-dTomato (AAV1)

   Viral Prep

   #135635-AAV1

   Purpose

   Ready-to-use AAV1 particles produced from pAAV-S5E2-Gq-P2A-dTomato (#135635). In addition to the viral particles, you will also receive purified pAAV-S5E2-Gq-P2A-dTomato plasmid DNA. Expression of Gq-DREADD and dTomato (physically separate) under the control of the E2 regulatory element. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Jordane Dimidschstein

   Article

   Vormstein-Schneider et al Nat Neurosci. 2020 Dec;23(12):1629-1636.

   Tags

   dTomato (physically separate, not a fusion protein)

   Available Since

   Nov. 29, 2021

   Availability

   Academic Institutions and Nonprofits only

2. pAAV-S5E6-dTom-nlsdTom (AAV1)

   Viral Prep

   #135641-AAV1

   Purpose

   Ready-to-use AAV1 particles produced from pAAV-S5E6-dTom-nlsdTom (#135641). In addition to the viral particles, you will also receive purified pAAV-S5E6-dTom-nlsdTom plasmid DNA. Bicistronic expression of dTomato and nuclear-targeted dTomato in VIP cortical interneurons under the control of the E6 regulatory element. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Jordane Dimidschstein

   Article

   Vormstein-Schneider et al Nat Neurosci. 2020 Dec;23(12):1629-1636.

   Tags

   dTomato

   Available Since

   Feb. 6, 2025

   Availability

   Academic Institutions and Nonprofits only

3. pAAV-S5E2-C1V1-eYFP (AAV5)

   Viral Prep

   #135633-AAV5

   Purpose

   Ready-to-use AAV5 particles produced from pAAV-S5E2-C1V1-eYFP (#135633). In addition to the viral particles, you will also receive purified pAAV-S5E2-C1V1-eYFP plasmid DNA. Expression of red-shifted opsin C1V1 fused to EYFP under the control of the E2 regulatory element. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Jordane Dimidschstein

   Article

   Vormstein-Schneider et al Nat Neurosci. 2020 Dec;23(12):1629-1636.

   Tags

   EYFP

   Available Since

   Oct. 8, 2020

   Availability

   Academic Institutions and Nonprofits only

4. pAAV-S5E2-C1V1-eYFP (AAV1)

   Viral Prep

   #135633-AAV1

   Purpose

   Ready-to-use AAV1 particles produced from pAAV-S5E2-C1V1-eYFP (#135633). In addition to the viral particles, you will also receive purified pAAV-S5E2-C1V1-eYFP plasmid DNA. Expression of red-shifted opsin C1V1 fused to EYFP under the control of the E2 regulatory element. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Jordane Dimidschstein

   Article

   Vormstein-Schneider et al Nat Neurosci. 2020 Dec;23(12):1629-1636.

   Tags

   EYFP

   Available Since

   Aug. 27, 2021

   Availability

   Academic Institutions and Nonprofits only

5. pAAV-S5E2-ChR2-mCherry (AAV PHP.eB)

   Viral Prep

   #135634-PHPeB

   Purpose

   Ready-to-use AAV PHP.eB particles produced from pAAV-S5E2-ChR2-mCherry (#135634). In addition to the viral particles, you will also receive purified pAAV-S5E2-ChR2-mCherry plasmid DNA. Expression of ChR2-mCherry under the control of the E2 regulatory element. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Jordane Dimidschstein

   Article

   Vormstein-Schneider et al Nat Neurosci. 2020 Dec;23(12):1629-1636.

   Tags

   mCherry

   Available Since

   Oct. 28, 2021

   Availability

   Academic Institutions and Nonprofits only

6. pAAV-S5E2-dTom-nlsdTom (AAV PHP.eB)

   Viral Prep

   #135630-PHPeB

   Purpose

   Ready-to-use AAV PHP.eB particles produced from pAAV-S5E2-dTom-nlsdTom (#135630). In addition to the viral particles, you will also receive purified pAAV-S5E2-dTom-nlsdTom plasmid DNA. Bicistronic expression of dTomato and nuclear-targeted dTomato under the control of the E2 regulatory element. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Jordane Dimidschstein

   Article

   Vormstein-Schneider et al Nat Neurosci. 2020 Dec;23(12):1629-1636.

   Tags

   dTomato

   Available Since

   Oct. 28, 2021

   Availability

   Academic Institutions and Nonprofits only

7. pAAV-S5E2-GFP-fGFP (AAV PHP.eB)

   Viral Prep

   #135631-PHPeB

   Purpose

   Ready-to-use AAV PHP.eB particles produced from pAAV-S5E2-GFP-fGFP (#135631). In addition to the viral particles, you will also receive purified pAAV-S5E2-GFP-fGFP plasmid DNA. Bicistronic expression of GFP and membrane-targeted GFP under the control of the E2 regulatory element. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Jordane Dimidschstein

   Article

   Vormstein-Schneider et al Nat Neurosci. 2020 Dec;23(12):1629-1636.

   Tags

   EGFP

   Available Since

   Nov. 29, 2021

   Availability

   Academic Institutions and Nonprofits only

8. pAAV-S5E2-Gq-P2A-dTomato (AAV PHP.eB)

   Viral Prep

   #135635-PHPeB

   Purpose

   Ready-to-use AAV PHP.eB particles produced from pAAV-S5E2-Gq-P2A-dTomato (#135635). In addition to the viral particles, you will also receive purified pAAV-S5E2-Gq-P2A-dTomato plasmid DNA. Expression of Gq-DREADD and dTomato (physically separate) under the control of the E2 regulatory element. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Jordane Dimidschstein

   Article

   Vormstein-Schneider et al Nat Neurosci. 2020 Dec;23(12):1629-1636.

   Tags

   dTomato (physically separate, not a fusion protein)

   Available Since

   Aug. 27, 2021

   Availability

   Academic Institutions and Nonprofits only

9. pAAV-S5E2-C1V1-eYFP (AAV PHP.eB)

   Viral Prep

   #135633-PHPeB

   Purpose

   Ready-to-use AAV PHP.eB particles produced from pAAV-S5E2-C1V1-eYFP (#135633). In addition to the viral particles, you will also receive purified pAAV-S5E2-C1V1-eYFP plasmid DNA. Expression of red-shifted opsin C1V1 fused to EYFP under the control of the E2 regulatory element. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Jordane Dimidschstein

   Article

   Vormstein-Schneider et al Nat Neurosci. 2020 Dec;23(12):1629-1636.

   Tags

   EYFP

   Available Since

   Aug. 27, 2021

   Availability

   Academic Institutions and Nonprofits only

10. pAAV.TBG.PI.eGFP.WPRE.bGH (AAV8)

    Viral Prep

    #105535-AAV8

    Purpose

    Ready-to-use AAV8 particles produced from pAAV.TBG.PI.eGFP.WPRE.bGH (#105535). In addition to the viral particles, you will also receive purified pAAV.TBG.PI.eGFP.WPRE.bGH plasmid DNA. TBG-driven eGFP expression. These AAV preparations are suitable purity for injection into animals.

    Depositor

    James M. Wilson

    Promoter

    TBG

    Tags

    EGFP

    Available Since

    April 30, 2018

    Availability

    Academic Institutions and Nonprofits only

11. pENN.AAV.CMVs.Pl.Cre.rBG (AAV1)

    Viral Prep

    #105537-AAV1

    Purpose

    Ready-to-use AAV1 particles produced from pENN.AAV.CMVs.Pl.Cre.rBG (#105537). In addition to the viral particles, you will also receive purified pENN.AAV.CMVs.Pl.Cre.rBG plasmid DNA. CMV-driven Cre. These AAV preparations are suitable purity for injection into animals.

    Depositor

    James M. Wilson

    Promoter

    CMV

    Available Since

    June 29, 2018

    Availability

    Academic Institutions and Nonprofits only

12. pAAV.TBG.PI.Null.bGH (AAV8)

    Viral Prep

    #105536-AAV8

    Purpose

    Ready-to-use AAV8 particles produced from pAAV.TBG.PI.Null.bGH (#105536). In addition to the viral particles, you will also receive purified pAAV.TBG.PI.Null.bGH plasmid DNA. AAV vector with TBG promoter. These AAV preparations are suitable purity for injection into animals.

    Depositor

    James M. Wilson

    Promoter

    TBG

    Available Since

    July 27, 2018

    Availability

    Academic Institutions and Nonprofits only

13. pENN.AAV.CMVs.Pl.Cre.rBG (AAV5)

    Viral Prep

    #105537-AAV5

    Purpose

    Ready-to-use AAV5 particles produced from pENN.AAV.CMVs.Pl.Cre.rBG (#105537). In addition to the viral particles, you will also receive purified pENN.AAV.CMVs.Pl.Cre.rBG plasmid DNA. CMV-driven Cre. These AAV preparations are suitable purity for injection into animals.

    Depositor

    James M. Wilson

    Promoter

    CMV

    Available Since

    Feb. 7, 2025

    Availability

    Academic Institutions and Nonprofits only

14. pAAV.CMV.PI.EGFP.WPRE.bGH (AAV2)

    Viral Prep

    #105530-AAV2

    Purpose

    Ready-to-use AAV2 particles produced from pAAV.CMV.PI.EGFP.WPRE.bGH (#105530). In addition to the viral particles, you will also receive purified pAAV.CMV.PI.EGFP.WPRE.bGH plasmid DNA. CMV-driven EGFP control. These AAV preparations are suitable purity for injection into animals.

    Depositor

    James M. Wilson

    Promoter

    CMV

    Tags

    EGFP

    Available Since

    June 29, 2018

    Availability

    Academic Institutions and Nonprofits only

15. pAAV.CMV.PI.EGFP.WPRE.bGH (AAV1)

    Viral Prep

    #105530-AAV1

    Purpose

    Ready-to-use AAV1 particles produced from pAAV.CMV.PI.EGFP.WPRE.bGH (#105530). In addition to the viral particles, you will also receive purified pAAV.CMV.PI.EGFP.WPRE.bGH plasmid DNA. CMV-driven EGFP control. These AAV preparations are suitable purity for injection into animals.

    Depositor

    James M. Wilson

    Promoter

    CMV

    Tags

    EGFP

    Available Since

    March 26, 2019

    Availability

    Academic Institutions and Nonprofits only

16. pENN.AAV.CMVs.Pl.Cre.rBG (AAV9)

    Viral Prep

    #105537-AAV9

    Purpose

    Ready-to-use AAV9 particles produced from pENN.AAV.CMVs.Pl.Cre.rBG (#105537). In addition to the viral particles, you will also receive purified pENN.AAV.CMVs.Pl.Cre.rBG plasmid DNA. CMV-driven Cre. These AAV preparations are suitable purity for injection into animals.

    Depositor

    James M. Wilson

    Promoter

    CMV

    Available Since

    June 29, 2018

    Availability

    Academic Institutions and Nonprofits only

17. pENN.AAV.CMVs.Pl.Cre.rBG (AAV2)

    Viral Prep

    #105537-AAV2

    Purpose

    Ready-to-use AAV2 particles produced from pENN.AAV.CMVs.Pl.Cre.rBG (#105537). In addition to the viral particles, you will also receive purified pENN.AAV.CMVs.Pl.Cre.rBG plasmid DNA. CMV-driven Cre. These AAV preparations are suitable purity for injection into animals.

    Depositor

    James M. Wilson

    Promoter

    CMV

    Available Since

    Sept. 18, 2018

    Availability

    Academic Institutions and Nonprofits only

18. pAAV.CMV.PI.EGFP.WPRE.bGH (AAV9)

    Viral Prep

    #105530-AAV9

    Purpose

    Ready-to-use AAV9 particles produced from pAAV.CMV.PI.EGFP.WPRE.bGH (#105530). In addition to the viral particles, you will also receive purified pAAV.CMV.PI.EGFP.WPRE.bGH plasmid DNA. CMV-driven EGFP control. These AAV preparations are suitable purity for injection into animals.

    Depositor

    James M. Wilson

    Promoter

    CMV

    Tags

    EGFP

    Available Since

    July 13, 2018

    Availability

    Academic Institutions and Nonprofits only

19. pAAV.hSyn.eGFP.WPRE.bGH (AAV1)

    Viral Prep

    #105539-AAV1

    Purpose

    Ready-to-use AAV1 particles produced from pAAV.hSyn.eGFP.WPRE.bGH (#105539). In addition to the viral particles, you will also receive purified pAAV.hSyn.eGFP.WPRE.bGH plasmid DNA. Synapsin-driven EGFP expression. These AAV preparations are suitable purity for injection into animals.

    Depositor

    James M. Wilson

    Promoter

    Syn

    Tags

    EGFP

    Available Since

    July 23, 2018

    Availability

    Academic Institutions and Nonprofits only

20. pAAV.CMV.PI.EGFP.WPRE.bGH (AAV5)

    Viral Prep

    #105530-AAV5

    Purpose

    Ready-to-use AAV5 particles produced from pAAV.CMV.PI.EGFP.WPRE.bGH (#105530). In addition to the viral particles, you will also receive purified pAAV.CMV.PI.EGFP.WPRE.bGH plasmid DNA. CMV-driven EGFP control. These AAV preparations are suitable purity for injection into animals.

    Depositor

    James M. Wilson

    Promoter

    CMV

    Tags

    EGFP

    Available Since

    June 1, 2018

    Availability

    Academic Institutions and Nonprofits only